iBio, Inc.
IBIO
$1.25
-$0.02-1.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.60M | -7.73M | -8.99M | -5.72M | -5.16M |
| Total Depreciation and Amortization | 250.00K | 250.00K | 241.00K | 289.00K | 285.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 471.00K | 2.79M | 2.72M | 295.00K | 255.00K |
| Change in Net Operating Assets | 3.65M | -1.39M | 792.00K | -529.00K | 8.00K |
| Cash from Operations | -6.23M | -6.08M | -5.24M | -5.67M | -4.62M |
| Capital Expenditure | -19.00K | -11.00K | -516.00K | -32.00K | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.39M | -3.10M | -2.47M | -21.46M | 46.00K |
| Cash from Investing | -4.41M | -3.11M | -2.98M | -21.49M | 45.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -614.00K | -160.00K | -183.00K |
| Issuance of Common Stock | 25.50M | 7.53M | 3.65M | 324.00K | 2.41M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.09M | 20.63M | 5.75M | 46.54M | 5.95M |
| Cash from Financing | 19.40M | 28.15M | 8.79M | 46.71M | 8.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.76M | 18.96M | 561.00K | 19.55M | 3.61M |